A BSTR A CT Incorporation of L-leucine-4C into proteins and immunoglobulins in vitro was determined in jejunal biopsy specimens from normal volunteers, patients with celiac sprue before and after introduction of gluten into the diet, patients with Whipple's disease in remission, and patients with immune deficiency states. Values for incorporation of L-leucine-4C into total and soluble protein by biopsies from five celiac sprue patients on a gluten-free diet were within, or slightly above, the 95% confidence limits for control data. One patient with celiac sprue and with normal intestinal histology had a normal value for incorporation into IgA; the other four patients with flat mucosas had elevated values. In Whipple's disease in remission, values for incorporation into total protein and IgA were within the control limits, whereas incorporation into soluble protein was increased. Patients with hypogammaglobulinemia or IgA deficiency had normal or elevated values for incorporation into total and soluble proteins; in these cases, however, no incorporation into IgA was detected.
Biopsies from the four celiac sprue patients studied revealed that with introduction of gluten into the diet (a) incorporation into total protein, soluble protein, or both, increased; (b) incorporation into IgA increased in all patients, and in two instances the increase was greater than the increase in incorporation into total protein; and (c) incorporation into IgM increased in all patients. The changes during gluten administration usually occurred before changes in gastrointestinal ab-
INTRODUCTION
It has become increasingly clear that the gastrointestinal tract can respond to exogenous antigens by the local production of antibodies which are secreted into the gastrointestinal tract lumen. Thus, oral immunization with live polio virus results in the appearance of antibodies in the gastrointestinal secretions, whereas parenteral immunization with killed virus produces an increase in serum antibodies, but does not produce detectable gastrointestinal antibodies (1, 2) . Since IgA is the major immunoglobulin found in gastrointestinal secretions (3) , and since IgA-containing cells are the predominant lymphoid cells in the gastrointestinal mucosa (4, 5) , it appears that local immune responses involving the gastrointestinal tract are mediated primarily through the IgA immunoglobulin system.
It is possible that the gastrointestinal immune system participates in the production of gastrointestinal disease. This could occur through the local elaboration of antibodies which react with gastrointestinal tissue or with dietary or bacterial protein bound to such tissue, with consequent cell destruction. A mechanism such as this might play a role in the pathophysiology of celiac sprue. Thus, it could be postulated that in this disease, gluten, or some other antigen, becomes bound to the intestinal epithelium, that antibodies specific for this antigen are then synthesized within the intestinal wall, and these antibodies react with the bound antigen to produce tissue damage. It would be important in pursuing such an hypothesis to know whether a system for local production of antibodies exists within the intestinal mucosa, and if it does, whether it responds when the patient is exposed to dietary gluten. In the present study we explored these questions by determining the incorporation in vitro of L-leucine--"C into immunoglobulins by specimens of jejunal mucosa from patients with celiac sprue and other diseases as a measure of gastrointestinal immunoglobulin synthesis. We found that in some patients with celiac sprue in remission while on gluten-free diets, local intestinal IgA synthesis exceeded that of control subjects and that in all celiac sprue patients intestinal production of IgA and IgM increased soon after reintroduction of gluten into the patients' diet.
METHODS

Patients
The 17 individuals studied included 6 
Clinical procedures
Jejunal biopsies were obtained with a four-hole multipurpose biopsy instrument, the capsule of which was positioned near the ligament of Treitz under fluoroscopic examination (6) . Each patient was biopsied one to four times, and an average of three specimens were obtained with each biopsy procedure. At least one specimen from each patient was used for microscopic examination. Specimens used for studies of protein synthesis were placed immediately on iced aluminum foil, gently blotted four times, weighed, and transferred to the incubation medium within 10 min after obtaining the biopsy.
Stool fats were determined by the method of Van der Kamer, ten Bokkel Huinink, and Weijers (7). The D-xylose tolerance test was performed by the administration of 25 g of the pentose and subsequent measurement of xylose in a 5 hr urine specimen. Serum immunoglobulins were measured quantitatively by the radial immunodiffusion technique (8) .
Assay of incorporation of L-leucine-14C into total protein and immunoglobulins Incubation conditions; total and soluble proteins. L-Leucine-Y4C incorporation into protein by jejunal mucosa in vitro was measured by a modification (9) of the method of Manchester and Young (10) . Each tissue specimen was incubated in 1.5 ml of Krebs-Ringer bicarbonate buffer (11) (modified to include one-half the recommended calcium concentration) to which was added: 0.05 ml of a solution containing 50 ,umoles each of 20 amino acids including Lleucine, 0.25 ml of 0.85% NaCl solution, and 0.2 ml of 0.85%o NaCl solution containing 10 ,uCi of uniformly labeled L-leucine-14C (34.6 ,moles of L-leucine (New England Nuclear, Boston, Mass.). Incubations were carried out in an atmosphere of 95% 02 and 5% C02 for periods of time ranging from 15 to 90 min. Incubations were terminated by transfer of the biopsy specimen, together with the incubation fluid, to an iced tissue homogenizer containing 1.0 ml of a solution containing 0.5% sodium deoxycholate (added to solubilize microsomal proteins [12] ) and 10 mM L-leucine. The specimens were homogenized immediately with 20 strokes and brought to a volume of 12.5 ml with 0.15 M NaCl-phosphate buffer pH 7 containing 10 mM Lleucine. Aliquots were taken in duplicate for determination of protein content (13) , and for determination of Lleucine-"'C incorporation into total protein. The homogenates were centrifuged at 100,000 g for 60 min, and duplicate aliquots were taken from the supernate for determination of L-leucine-l'C incorporation into immunoglobulins.
To measure L-leucine-1C incorporation into total and soluble proteins, protein was precipitated from the initial tissue homogenate (total protein) and the supernatant solutions of these homogenates (soluble protein), which had been centrifuged at 100,000 g. Proteins were precipitated by addition of 20% TCA1 containing 10 mM L-leucine to an equal volume of homogenate or of the 100,000 g supernatant solution. The precipitates were separated by centrifugation at 2600 g, and then resuspended in 10% TCA containing 5 mM L-leucine, heated at 90°C in a water bath for 15 min, washed three times with the TCA-leucine solu-'Abbreviations used in this paper: DPO, 2,5-diphenyloxazole; NCS, N-chlorsuccinimide; PAS, para-aminosalicylic acid; RGG, rabbit gammaglobulin; TCA, trichloroacetic acid. tion and once each with ethanol: ether (1: 1) and ether. The dry precipitates were dissolved in 1 ml NCS solvent, and the NCS solution was dissolved in 13 ml of 0.435%o DPO and toluene in glass counting vials for determination of radioactivity in a liquid scintillation spectrometer. Values for counts per minute were converted to disintegrations per minute by the channels ratio method (14) .
Immunological reagents. Specific antisera were prepared in order to measure incorporation of L-leucine-j"C into immunoglobulins. IgG-'lI was bound.
To prove that the values for nonspecific counts bound by the specific anti-immunoglobulin precipitates (IgA-antiIgA or IgM-anti-IgM precipitates) were the same as the values for the counts bound by the RGG-anti-RGG precipitates, the following experiment was performed. IgAanti-IgA precipitates were formed in two separate tubes containing labeled biopsy homogenates by adding anti-IgA and carrier IgA. The precipitates bound labeled IgA as well as nonspecific counts. The precipitates were then removed and additional anti-IgA and carrier IgA were added to the supernatant solution in one tube and anti-RGG and carrier RGG were added to the second tube. The new precipitates bound an equal number of counts, indicating that they had an equivalent capacity to bind nonspecific counts when labeled IgA was not present.
To prove that RGG-anti-RGG precipitates do not bind labeled IgA, the values for IgA counts were determined by two different procedures (Table I ) and compared. In procedure I, which was used routinely in the present studies, two tubes were prepared, each containing labeled homogenate. Anti-IgA and carrier IgA were added to tube 1 and anti-RGG and carrier RGG were added to tube 2. The value for counts brought down by the RGG-anti-RGG precipitate was subtracted from the value for counts brought down by the IgA-anti-IgA precipitate to obtain a value of 1013 cpm for the amount of labeled IgA in the homogenate. Relation of L-leucine-"C incorporation to protein and immunoglobulin synthesis. Incorporation of L-leucine-1'C into a protein can be related quantitatively to the synthesis of the protein only if the specific activity of the amino acid precursor pool and the degradation rate of the protein are known (15) . We attempted to diminish variation in the amino acid precursor pool in the present studies by adding a mixture of amino acids containing unlabeled leucine to the incubation mixtures. We did not, however, make direct measurements of intracellular precursor pool specific activity or protein degradation rates; therefore, conclusions we draw about rates of synthesis of proteins from the incorporation data are dependent on the reasonable assumption that these activities and rates were constant.
When an inhibitor of protein synthesis, puromycin (Nutritional Biochemicals Corp., Cleveland, Ohio), was added to the incubation medium in a final concentration of 1 mmole/ml, L-leucine-14C, incorporation into total protein was reduced by 89%o, incorporation into soluble protein by 88%, incorporation into IgA by 93%o, and incorporation into IgM by 100%. These observations provide evidence that L-leucine-"C incorporation reflects protein synthesis.
Kinetics of L-leucine-"C incorporation into proteins. When the data are plotted on a linear graph, the relation between incorporation of L-leucine-14C into protein (disintegrations per minute per milligram tissue protein) and incubation time is represented by a curved line (Fig. 1 A) . When plotted on a log-log graph, the data fall on a straight line (Fig. 1 B) . The fact that linearity is obtained by plotting the data in logarithmic form implies that for every fractional change in time there is a constant fractional change in incorporation over the time period studied. This would be expected if the amino acid incorporation process were the product of multiple linear steps.
Statistical analysis of data. Data for incorporation of L-leucine-14C were plotted logarithmically and fitted with regression lines by means of the least squares technique (Fig. 2) (Table II) were normal in all patients studied except for one patient (A. C.) with celiac sprue in remission, and the patients with immune deficiency states. A. C. had an elevated concentration of IgA in serum, and the patients with hypogammaglobulinemia, the patient with ataxia telangiectasia, and the patient with isolated calcium malabsorption had no detectable IgA in their serum.
Incorporation of L-leucine-`4C into total and soluble protein. The mean control value for intestinal incorporation of L-leucine-14C into total protein (Fig. 3 A) established in eight studies of six normal volunteers was 156,700 dpm/mg protein per hr with 95% confidence limits (mean ±2 SD) of 103,400-237,300. The patients with celiac sprue were studied when they were in remission on a gluten-free diet. The value for G. K., the patient with normal intestinal histology, and for two of the four patients with villous flattening were within the 95% confidence limit of the control data, whereas the values for the remaining two patients were elevated. The values for the patients with Whipple's disease in remission and patients with hypogammaglobulinemia were within the 95% confidence limits of the control data. The values for the two patients with isolated IgA deficiency were somewhat elevated. The values for incorporation of L-leucine-14C into soluble protein (Fig. 3 B) revealed generally similar results. Once again, the values for two of the five patients with celiac sprue were elevated, as were the values for each patient with isolated IgA deficiency. In this case, however, the values for the patients with Whipple's disease and for one of the patients with hypogammaglobulinemia were greater than the upper 95% confidence limits of the control data.
Incorporation. of L-leucine-14C into IgA and IgM. The mean control value for intestinal incorporation of L-leucine,-.4C into IgA (Fig. 4 A) IgA deficiency.
For all but one of the normal volunteers studied, the intestinal incorporation of L-leucine--"C into IgM (Fig. 4 B) L-leucine--4C into total protein, soluble protein, IgA, and IgM was determined.
Histological and laboratory findings. Histological examination of the jejunal biopsy specimens obtained from the four patients during gluten challenge demonstrated no change in villus-crypt ratios or mucosal thickness. However, the intestinal epithelial cells became more cuboidal and the nuclei were displaced from their normal basal location.
With one exception, there was no apparent change in the determined parameters of intestinal absorption of fat and carbohydrate during the period of gluten administration at the time jejunal biopsies were taken (Fig. 5) . L. H., who had slight steatorrhea at the termination of the gluten administration, excreted 22.6 g of fat per day in her stool at the termination of the gluten challenge. The concentration of IgA in serum did not change during the period of gluten administration (Table II) .
Incorporation of L-leucine-4C into total protein and soluble protein. After patient G. K., with normal jejunal histology, was on a gluten-containing diet for 6 days, his intestinal incorporation of L-leucine-Y4C into total protein was 60% higher than it was when he was on a gluten-free diet (Fig. 6A) . Although the higher value was still within the 95% confidence limit of the control data, the increase was statistically significant (P < 0.05). Of the three patients with flattened intestinal mucosa studied, only one (M. C.) had a statistically significant (P < 0.05) increase (300%) in incorporation of labeled leucine into total protein. This increase was evident on the 12th day after institution of the glutencontaining diet but not on the 9th day. The values for the other two patients, L. B. and L. H., increased, but not significantly (30 and 4%, respectively).
The effects of a gluten-containing diet on intestinal incorporation of L-leucine-14C into soluble protein (Fig.  6 B) were generally similar to the effects on incorporation into total protein. A 30% increase in incorporation was detected for G. K. but this was not significant. Significant (P <0.05) increases were observed for M. C. (300%) and for L. H. (50% after 16 days) . The increase (30%) observed for L. B. was not significant.
In summary, it appears that for three of the four patients studied there was an increase in incorporation of L-leucine--'4C into total protein, soluble protein, or both, after a brief exposure to a gluten-containing diet. These findings complement earlier studies (16) which showed increased incorporation of L-leucine-"C into total protein by jejunal biopsy specimens of, patients with celiac sprue. The increased L-leucine-1'C incorporation into protein shown in those and the present studies can be related to the abnormal cell turnover observed by Creamer (17) Incorporation of L-leucine-'4C into IgA. Intestinal incorporation of L-leucine---4C into IgA increased significantly for all four patients after they were challenged with gluten-containing diets (Fig. 7 A) . Patient G. K., whose value for incorporation into IgA was within the 95% confidence limits of the control data before challenge, had a 3-fold increase in incorporation (from 3912 to 12,970 dpm/mg protein per hr) after challenge. The other patients, whose values for incorporation into IgA were well above the 95% confidence limits of the control data while they were on a gluten-free diet, had a 2-to 3-fold increase (P < 0.05) in the value for L-leucine-'4C incorporation into IgA after challenge with a gluten-containing diet. For three of the four patients the increase in incorporation of L-leucine-2"C into IgA occurred before gastrointestinal absorptive changes were detected.
Because the incorporation of L-leucine--"C into total protein increased in some of the patients with celiac sprue after gluten challenge, we determined whether the fractional change in incorporation into IgA was greater than the fractional change in incorporation into total protein. In the studies of G. K., incorporation into IgA increased 3.3-fold, whereas incorporation into total protein increased 1.6-fold after gluten challenge. Thus, the fractional change in incorporation into IgA was twice the fractional change in incorporation into total protein. In the studies of the other three patients, the fractional increase in incorporation of L-leucine-14C into IgA exceeded that of incorporation into total protein by factors of 1.6, 1.5, and 1.1. In all, the fractional change in incorporation into IgA was significantly greater than the change in incorporation into total protein for two of the four patients (P < 0.1).
Incorporation of L-leucine--"C into IgM. There was insufficient data to determine day-to-day variation in the studies of incorporation of L-leucine-14C into IgM. If one assumes that, as in the case of IgA, such variation was negligible, each of the patients studied showed a significant (P <0.05) increase in incorporation of L-leucine-14C into IgM (Fig. 7B ).
Studies in normal volunteers maintained on a gluten-free diet and then challenged with dietary gluten
We considered the possibility that the effect we observed by gluten on intestinal immunoglobulin synthesis in patients with celiac sprue was a nonspecific phenomenon attributable to abrupt reexposure to gluten after a period of gluten deprivation. As a control investigation, we studied three normal volunteers who were fed glutenfree diets for 3 wk, subjected to intestinal biopsies, placed on normal gluten-containing diets, and then subjected to intestinal biopsies again after 7 days. During these studies the fecal excretion of fat by the subjects did not change significantly.
In the study of the first volunteer the biopsy specimens were assayed for IgA synthesis as described under Methods. In the studies of the remaining two volunteers a modified and improved assay procedure was used.2 In this procedure the biopsy specimens were incubated with L-leucine--'4C as before, but the newly synthesized, labeled IgA was isolated by use of a complex comprising specific anti-IgA antibodies covalently coupled to cellulose. After the incubation with L-leucine--14C, the biopsy specimen was homogenized and exposed to the anti-IgAcellulose complex so that the 14C-labeled IgA was bound specifically to the complex. The complex, together with the bound IgA-14C, was isolated by filtration and counted directly on a filter paper disc. The value for nonspecific binding in this procedure was obtained from the number of counts bound after incubation of labeled homogenate with anti-IgA-cellulose previously exposed to an excess of unlabeled IgA. Fig. 4A ).
For the volunteers studied, the values for incorporation of L-leucine--14C into IgA did not differ significantly (P > 0.6) in biopsies obtained before and after the exposure to dietary gluten (Table III) . These observations show that when normal individuals are deprived of gluten for 3 wk and then exposed to this protein, there is no stimulation of incorporation of L-leucine--14C into IgA by intestinal mucosa as occurs in patients with celiac sprue.
DISCUSSION
The results of the present studies of the incorporation of L-leucine--4C into protein by intestinal mucosal biopsies lead to two conclusions. First, the human small intestine mucosa is capable of local synthesis of immunoglobulins and, second, in patients with celiac sprue, this local mechanism responds to exposure to dietary gluten by increasing the production of IgA and IgM. Furthermore, the effect of dietary gluten on intestinal incorporation of L-leucine-14C into immunoglobulins exceeded the effect on incorporation into total protein in at least two of the patients studied. Thus, even if one were to assume that immunoglobulin production could increase through a mechanism other than one involving antigenic stimulation, the present results indicate that it is unlikely that the observed increased incorporation of L-leucine-14C into immunoglobulins was merely a nonspecific reflection of a generalized stimulation of protein synthesis.
When the four celiac sprue patients with flattened mucosa (but not the one with histologically normal mucosa) were on a gluten-free diet, their biopsy specimens incorporated more L-leucine--4C into immunoglobulins than did specimens from control subjects. This difference may be due to persistent stimulation by small amounts of dietary gluten, or to the possibility that measurements obtained with a biopsy specimen of flat mucosa are not strictly comparable to those obtained with a normal specimen. However, the latter alternative does not explain differences we observed for an individual before and after introduction of gluten into the diet. In those instances, the specimens were histologically comparable, and changes in L-leucine--14C incorporation most probably reflected true differences among rates of intestinal synthesis of immunoglobulins.
The present demonstration of a local intestinal immune response bears on the question of whether or not immunologic reactions play a role in the pathogenesis of celiac sprue. The improvement in patients with celiac sprue noted after treatment with adrenal steroids may be one indication of such a role (18 (19, 20, 22 t Assayed by anti-IgA-cellulose. (23) and by the observation that the presence of secretory IgA in serum did not correlate with the concentration of IgA in serum or with the activity of the disease. The other abnormality in serum immunoglobulins, the reduced concentration of IgM in celiac sprue patients, is also not well understood. Despite the low concentration of IgM in serum, and despite the detection of decreased total body synthesis of IgM in this disease, as determined by turnover studies (24) , the number of intestinal mucosal plasma cells containing IgM was found to be increased (20) . The concentration of IgM in serum does not appear related to the severity of the disease (19, 22) or to the presence of splenic atrophy (24, 25) .
Specific circulating antibodies to gluten and gluten fractions were found by several investigators in celiac sprue (26) (27) (28) (29) (31) . However, if they were in the IgG class, it would be possible that they were transported from the serum, since about 50% of IgG immunoglobulins in external secretions are derived from the serum (31) .
The present studies indicate that increased immunoglobulin synthesis does indeed occur locally in the gastrointestinal tract after gluten challenge, and moreover, that the increase in synthesis takes place soon after the introduction of gluten into the diet, and generally before functional gastrointestinal disturbances can be observed. These findings lend greater weight to the supposition that immune mechanisms are involved as one of the primary factors in the pathophysiology of celiac sprue. Thus, the proximity of an immune mechanism to the site of initial exposure to gluten makes it reasonable to postulate that an immunological reaction plays a role in the initiation of the intestinal lesion.
The additional immunoglobulins produced after gluten challenge may be specific for gluten, for other exogenous proteins, or for proteins of the epithelium which gain access to antibody-producing cells through the disruptive action of gluten. Since Rubin, Fauci, Sleisenger, and Jeffries (5) presented evidence that gluten binds to the epithelial cells of patients with celiac sprue but not those of normal individuals, it may well be that the excess immunoglobulins are composed largely of anti-gluten antibodies. Such antibodies would be free to react with gluten on epithelial cell membranes and could thereby lead to immune destruction of the epithelial cells.
